Characteristics of the group of patients participating in the survey.
\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 179 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 252 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
\n'}],latestNews:[{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"}]},book:{item:{type:"book",id:"5941",leadTitle:null,fullTitle:"Fundamentals of Sexually Transmitted Infections",title:"Fundamentals of Sexually Transmitted Infections",subtitle:null,reviewType:"peer-reviewed",abstract:"This textbook includes the recent progresses and scientific knowledge from the leading experts in different approaches to control, diagnosis, and management depending on resources and facilities available. This book has been written by our colleagues from all over the world. This book is divided into six sections. Each section supplies particularly sexually transmitted infections, diagnostics, microorganism types, pathogenesis, and treatment options. Essential points in publishing this book are to improve our knowledge about sexually transmitted infections and new treatment modalities. One chapter of the book is devoted to viral infections and their treatment. We think that this textbook will serve as a comprehensive guide to many physicians dealing with sexually transmitted infections in their clinical practice. It will hopefully be a precious source for dermatologists, educators, other physicians, and medical students.",isbn:"978-953-51-3518-0",printIsbn:"978-953-51-3517-3",pdfIsbn:"978-953-51-4676-6",doi:"10.5772/66060",price:119,priceEur:129,priceUsd:155,slug:"fundamentals-of-sexually-transmitted-infections",numberOfPages:228,isOpenForSubmission:!1,isInWos:1,hash:"213a3a4ce4fd55711c78e9a7acaf6939",bookSignature:"Server Serdaroglu and Zekayi Kutlubay",publishedDate:"September 6th 2017",coverURL:"https://cdn.intechopen.com/books/images_new/5941.jpg",numberOfDownloads:10063,numberOfWosCitations:4,numberOfCrossrefCitations:4,numberOfDimensionsCitations:8,hasAltmetrics:1,numberOfTotalCitations:16,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"November 3rd 2016",dateEndSecondStepPublish:"November 24th 2016",dateEndThirdStepPublish:"February 20th 2017",dateEndFourthStepPublish:"May 21st 2017",dateEndFifthStepPublish:"July 20th 2017",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"64792",title:"Dr.",name:"Zekayi",middleName:null,surname:"Kutlubay",slug:"zekayi-kutlubay",fullName:"Zekayi Kutlubay",profilePictureURL:"https://mts.intechopen.com/storage/users/64792/images/5583_n.png",biography:"Zekayi Kutlubay, MD, is a chief physician of Istanbul University Cerrahpasa Medical Faculty Hospital. He is also an associate professor in the Department of Dermatology at Istanbul University Cerrahpasa Medical Faculty in Turkey. He has coauthored over 40 publications and supervised several master, doctoral, and postdoctoral students. His actual research interests are focused on psoriasis, pediatric dermatology, autoimmune bullous diseases, urticaria and allergic diseases, Behçet’s disease, vasculitis, lasers, cosmetic dermatology, facial rejuvenation, hair diseases, mesotherapy, botulinum toxin, and fillers.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"5",totalChapterViews:"0",totalEditedBooks:"2",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"64794",title:"Mr.",name:"Server",middleName:null,surname:"Serdaroglu",slug:"server-serdaroglu",fullName:"Server Serdaroglu",profilePictureURL:"https://mts.intechopen.com/storage/users/64794/images/5584_n.png",biography:"Server Serdaroglu, MD, is the head of the Department of Dermatology at Istanbul University Cerrahpasa Medical Faculty. He is also a professor in the Department of Dermatology at Istanbul University Cerrahpasa Medical Faculty in Turkey. He has coauthored over 30 publications and supervised several master, doctoral, and postdoctoral students. His actual research interests are focused on psoriasis, hair diseases, pediatric dermatology, autoimmune bullous diseases, urticaria and allergic diseases, lasers, and cosmetic dermatology.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1046",title:"Infectious Diseases",slug:"infectious-diseases"}],chapters:[{id:"56155",title:"Introductory Chapter: The Latest Knowledge",doi:"10.5772/intechopen.69261",slug:"introductory-chapter-the-latest-knowledge",totalDownloads:953,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Gürkan Yardımcı, Server Serdaroğlu and Zekayi Kutlubay",downloadPdfUrl:"/chapter/pdf-download/56155",previewPdfUrl:"/chapter/pdf-preview/56155",authors:[{id:"64792",title:"Dr.",name:"Zekayi",surname:"Kutlubay",slug:"zekayi-kutlubay",fullName:"Zekayi Kutlubay"}],corrections:null},{id:"56433",title:"Anogenital HPV",doi:"10.5772/intechopen.70017",slug:"anogenital-hpv",totalDownloads:963,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Özge Aşkın",downloadPdfUrl:"/chapter/pdf-download/56433",previewPdfUrl:"/chapter/pdf-preview/56433",authors:[{id:"204824",title:"Dr.",name:"Özge",surname:"Aşkın",slug:"ozge-askin",fullName:"Özge Aşkın"}],corrections:null},{id:"55980",title:"Cervical Cancer, a Sequela of a Sexually Transmitted Infection: The Human Papillomavirus Infection",doi:"10.5772/intechopen.69259",slug:"cervical-cancer-a-sequela-of-a-sexually-transmitted-infection-the-human-papillomavirus-infection",totalDownloads:831,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Tamunomie K Nyengidiki, Goddy Bassey and Ikechukwu Durugbo",downloadPdfUrl:"/chapter/pdf-download/55980",previewPdfUrl:"/chapter/pdf-preview/55980",authors:[{id:"171742",title:"Dr.",name:"Nyengidiki",surname:"Tamunomie",slug:"nyengidiki-tamunomie",fullName:"Nyengidiki Tamunomie"},{id:"202597",title:"Dr.",name:"Durugbo",surname:"Ikechekwu",slug:"durugbo-ikechekwu",fullName:"Durugbo Ikechekwu"},{id:"206990",title:"Dr.",name:"Bassey",surname:"Goddy",slug:"bassey-goddy",fullName:"Bassey Goddy"}],corrections:null},{id:"56376",title:"Genital Herpes",doi:"10.5772/intechopen.70105",slug:"genital-herpes",totalDownloads:1018,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Selma Emre and Ayse Akkus",downloadPdfUrl:"/chapter/pdf-download/56376",previewPdfUrl:"/chapter/pdf-preview/56376",authors:[{id:"212484",title:"Ms.",name:"Ayse",surname:"Akkus",slug:"ayse-akkus",fullName:"Ayse Akkus"},{id:"213788",title:"Dr.",name:"Selma",surname:"Emre",slug:"selma-emre",fullName:"Selma Emre"}],corrections:null},{id:"56549",title:"Bacterial Vaginosis and Sexually Transmitted Diseases: Relationship and Management",doi:"10.5772/intechopen.69258",slug:"bacterial-vaginosis-and-sexually-transmitted-diseases-relationship-and-management",totalDownloads:1814,totalCrossrefCites:3,totalDimensionsCites:4,signatures:"Marco Bertini",downloadPdfUrl:"/chapter/pdf-download/56549",previewPdfUrl:"/chapter/pdf-preview/56549",authors:[{id:"200557",title:"Ph.D.",name:"Marco",surname:"Bertini",slug:"marco-bertini",fullName:"Marco Bertini"}],corrections:null},{id:"56658",title:"Syphilis",doi:"10.5772/intechopen.70282",slug:"syphilis",totalDownloads:768,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Ayşegül Sevim Keçici",downloadPdfUrl:"/chapter/pdf-download/56658",previewPdfUrl:"/chapter/pdf-preview/56658",authors:[{id:"215974",title:"Dr.",name:"Aysegul Sevim",surname:"Kecici",slug:"aysegul-sevim-kecici",fullName:"Aysegul Sevim Kecici"}],corrections:null},{id:"56267",title:"Microbicides for the Prevention of HPV, HIV-1, and HSV-2: Sexually Transmitted Viral Infections",doi:"10.5772/intechopen.68927",slug:"microbicides-for-the-prevention-of-hpv-hiv-1-and-hsv-2-sexually-transmitted-viral-infections",totalDownloads:940,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Naveed Shahzad, Roman Farooq, Bilal Aslam and Muhammad\nUmer",downloadPdfUrl:"/chapter/pdf-download/56267",previewPdfUrl:"/chapter/pdf-preview/56267",authors:[{id:"180702",title:"Dr.",name:"Hafiz",surname:"Shahzad",slug:"hafiz-shahzad",fullName:"Hafiz Shahzad"},{id:"185903",title:"Dr.",name:"Bilal",surname:"Aslam",slug:"bilal-aslam",fullName:"Bilal Aslam"},{id:"185904",title:"Dr.",name:"Muhammad",surname:"Umer",slug:"muhammad-umer",fullName:"Muhammad Umer"},{id:"202558",title:"Mr.",name:"Roman",surname:"Farooq",slug:"roman-farooq",fullName:"Roman Farooq"}],corrections:null},{id:"55196",title:"Circumcision and Sexually Transmitted Disease Prevention: Evidence and Reticence",doi:"10.5772/intechopen.68644",slug:"circumcision-and-sexually-transmitted-disease-prevention-evidence-and-reticence",totalDownloads:958,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Marco Vella, Alberto Abrate, Antonina Argo and Alchiede\nSimonato",downloadPdfUrl:"/chapter/pdf-download/55196",previewPdfUrl:"/chapter/pdf-preview/55196",authors:[{id:"201774",title:"Dr.",name:"Antonina",surname:"Argo",slug:"antonina-argo",fullName:"Antonina Argo"},{id:"204696",title:"Dr.",name:"Marco",surname:"Vella",slug:"marco-vella",fullName:"Marco Vella"},{id:"206091",title:"Dr.",name:"Alberto",surname:"Abrate",slug:"alberto-abrate",fullName:"Alberto Abrate"},{id:"206092",title:"Prof.",name:"Alchiede",surname:"Simonato",slug:"alchiede-simonato",fullName:"Alchiede Simonato"}],corrections:null},{id:"55344",title:"Infection by Human Papillomavirus (HPV), Chlamydia trachomatis and Ureaplasma urealyticum, in Relation with Reproductive Failure",doi:"10.5772/intechopen.68696",slug:"infection-by-human-papillomavirus-hpv-chlamydia-trachomatis-and-ureaplasma-urealyticum-in-relation-w",totalDownloads:975,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Adriana Ancer‐Arellano, Jesus Ancer‐Rodríguez, David Hardisson,\nAlberto Niderhauser-Garcia, Jose Sanchez‐Hernández, Alvarez‐\nCuevas Salomón and Guadalupe Gallegos‐Avila",downloadPdfUrl:"/chapter/pdf-download/55344",previewPdfUrl:"/chapter/pdf-preview/55344",authors:[{id:"88479",title:"Dr.",name:"Guadalupe",surname:"Gallegos-Avila",slug:"guadalupe-gallegos-avila",fullName:"Guadalupe Gallegos-Avila"},{id:"88481",title:"Dr.",name:"Salomon",surname:"Alvarez-Cuevas",slug:"salomon-alvarez-cuevas",fullName:"Salomon Alvarez-Cuevas"},{id:"203337",title:"Dr.",name:"David",surname:"Hardisson-Hernaez",slug:"david-hardisson-hernaez",fullName:"David Hardisson-Hernaez"},{id:"203339",title:"Dr.",name:"Adriana",surname:"Ancer-Arellano",slug:"adriana-ancer-arellano",fullName:"Adriana Ancer-Arellano"},{id:"203341",title:"Dr.",name:"Jesus",surname:"Ancer-Rodriguez",slug:"jesus-ancer-rodriguez",fullName:"Jesus Ancer-Rodriguez"},{id:"205673",title:"Dr.",name:"Jose",surname:"Sanchez-Hernandez",slug:"jose-sanchez-hernandez",fullName:"Jose Sanchez-Hernandez"}],corrections:null},{id:"55328",title:"Communicable Diseases Among Refugees with a Focus on the Middle East",doi:"10.5772/intechopen.68901",slug:"communicable-diseases-among-refugees-with-a-focus-on-the-middle-east",totalDownloads:853,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Inaya Hajj Hussein, Ibrahim Mortada, Alice Gerges Geagea and\nAbdo Jurjus",downloadPdfUrl:"/chapter/pdf-download/55328",previewPdfUrl:"/chapter/pdf-preview/55328",authors:[{id:"63795",title:"Prof.",name:"Abdo",surname:"Jurjus",slug:"abdo-jurjus",fullName:"Abdo Jurjus"},{id:"200452",title:"Associate Prof.",name:"Inaya",surname:"Hajj Hussein",slug:"inaya-hajj-hussein",fullName:"Inaya Hajj Hussein"},{id:"201225",title:"Dr.",name:"Ibrahim",surname:"Mortada",slug:"ibrahim-mortada",fullName:"Ibrahim Mortada"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"5461",title:"Hair and Scalp Disorders",subtitle:null,isOpenForSubmission:!1,hash:"87c272cade1ee498e1b4d6051aa8d41e",slug:"hair-and-scalp-disorders",bookSignature:"Zekayi Kutlubay and Server Serdaroglu",coverURL:"https://cdn.intechopen.com/books/images_new/5461.jpg",editedByType:"Edited by",editors:[{id:"64792",title:"Dr.",name:"Zekayi",surname:"Kutlubay",slug:"zekayi-kutlubay",fullName:"Zekayi Kutlubay"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"825",title:"Current Topics in Tropical Medicine",subtitle:null,isOpenForSubmission:!1,hash:"ef65e8eb7a2ada65f2bc939aa73009e3",slug:"current-topics-in-tropical-medicine",bookSignature:"Alfonso J. Rodriguez-Morales",coverURL:"https://cdn.intechopen.com/books/images_new/825.jpg",editedByType:"Edited by",editors:[{id:"131400",title:"Dr.",name:"Alfonso J.",surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"799",title:"Salmonella",subtitle:"A Dangerous Foodborne Pathogen",isOpenForSubmission:!1,hash:"ba452d8a24ef16b1267d2854b28f6e6a",slug:"salmonella-a-dangerous-foodborne-pathogen",bookSignature:"Barakat S. M. Mahmoud",coverURL:"https://cdn.intechopen.com/books/images_new/799.jpg",editedByType:"Edited by",editors:[{id:"92016",title:"Dr.",name:"Barakat",surname:"Mahmoud",slug:"barakat-mahmoud",fullName:"Barakat Mahmoud"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"322",title:"Flavivirus Encephalitis",subtitle:null,isOpenForSubmission:!1,hash:"269535b3a2f21a46216f4ca6925aa8f1",slug:"flavivirus-encephalitis",bookSignature:"Daniel Růžek",coverURL:"https://cdn.intechopen.com/books/images_new/322.jpg",editedByType:"Edited by",editors:[{id:"33830",title:"Dr.",name:"Daniel",surname:"Ruzek",slug:"daniel-ruzek",fullName:"Daniel Ruzek"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2068",title:"Understanding Tuberculosis",subtitle:"New Approaches to Fighting Against Drug Resistance",isOpenForSubmission:!1,hash:"077a11a53e4b135020092b8c1143f93c",slug:"understanding-tuberculosis-new-approaches-to-fighting-against-drug-resistance",bookSignature:"Pere-Joan Cardona",coverURL:"https://cdn.intechopen.com/books/images_new/2068.jpg",editedByType:"Edited by",editors:[{id:"78269",title:"Associate Prof.",name:"Pere-Joan",surname:"Cardona",slug:"pere-joan-cardona",fullName:"Pere-Joan Cardona"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3842",title:"Leishmaniasis",subtitle:"Trends in Epidemiology, Diagnosis and Treatment",isOpenForSubmission:!1,hash:"861f3ca84eede677ba6cd863093d62f8",slug:"leishmaniasis-trends-in-epidemiology-diagnosis-and-treatment",bookSignature:"David M. Claborn",coverURL:"https://cdn.intechopen.com/books/images_new/3842.jpg",editedByType:"Edited by",editors:[{id:"169536",title:"Dr.",name:"David",surname:"Claborn",slug:"david-claborn",fullName:"David Claborn"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"977",title:"Understanding Tuberculosis",subtitle:"Global Experiences and Innovative Approaches to the Diagnosis",isOpenForSubmission:!1,hash:"cb8288ea48f14bd22680c6ae5b13745b",slug:"understanding-tuberculosis-global-experiences-and-innovative-approaches-to-the-diagnosis",bookSignature:"Pere-Joan Cardona",coverURL:"https://cdn.intechopen.com/books/images_new/977.jpg",editedByType:"Edited by",editors:[{id:"78269",title:"Associate Prof.",name:"Pere-Joan",surname:"Cardona",slug:"pere-joan-cardona",fullName:"Pere-Joan Cardona"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"971",title:"Malaria Parasites",subtitle:null,isOpenForSubmission:!1,hash:"d7a9d672f9988a6d5b059aed14188896",slug:"malaria-parasites",bookSignature:"Omolade O. Okwa",coverURL:"https://cdn.intechopen.com/books/images_new/971.jpg",editedByType:"Edited by",editors:[{id:"99780",title:"Associate Prof.",name:"Omolade Olayinka",surname:"Okwa",slug:"omolade-olayinka-okwa",fullName:"Omolade Olayinka Okwa"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1273",title:"Non-Flavivirus Encephalitis",subtitle:null,isOpenForSubmission:!1,hash:"fa857119b76ce546ccf16503e982a08e",slug:"non-flavivirus-encephalitis",bookSignature:"Sergey Tkachev",coverURL:"https://cdn.intechopen.com/books/images_new/1273.jpg",editedByType:"Edited by",editors:[{id:"62638",title:"Dr.",name:"Sergey",surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"66065",slug:"corrigendum-to-eating-disorders-as-new-forms-of-addiction",title:"Corrigendum to: Eating Disorders as New Forms of Addiction",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/66065.pdf",downloadPdfUrl:"/chapter/pdf-download/66065",previewPdfUrl:"/chapter/pdf-preview/66065",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/66065",risUrl:"/chapter/ris/66065",chapter:{id:"52200",slug:"eating-disorders-as-new-forms-of-addiction",signatures:"Francisco J. Vaz-Leal, María I. Ramos-Fuentes, Laura Rodríguez-\nSantos and M. Cristina Álvarez-Mateos",dateSubmitted:"April 9th 2016",dateReviewed:"August 12th 2016",datePrePublished:null,datePublished:"February 1st 2017",book:{id:"5372",title:"Eating Disorders",subtitle:"A Paradigm of the Biopsychosocial Model of Illness",fullTitle:"Eating Disorders - A Paradigm of the Biopsychosocial Model of Illness",slug:"eating-disorders-a-paradigm-of-the-biopsychosocial-model-of-illness",publishedDate:"February 1st 2017",bookSignature:"Ignacio Jauregui-Lobera",coverURL:"https://cdn.intechopen.com/books/images_new/5372.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"55769",title:"Prof.",name:"Ignacio",middleName:null,surname:"Jáuregui Lobera",slug:"ignacio-jauregui-lobera",fullName:"Ignacio Jáuregui Lobera"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"188555",title:"Prof.",name:"Francisco J.",middleName:null,surname:"Vaz-Leal",fullName:"Francisco J. Vaz-Leal",slug:"francisco-j.-vaz-leal",email:"fjvazleal@gmail.com",position:null,institution:null},{id:"188719",title:"Dr.",name:"María Cristina",middleName:null,surname:"Álvarez Mateos",fullName:"María Cristina Álvarez Mateos",slug:"maria-cristina-alvarez-mateos",email:"cristinaalvarezmateos@gmail.com",position:null,institution:null},{id:"195142",title:"Dr.",name:"Laura",middleName:null,surname:"Rodríguez Santos",fullName:"Laura Rodríguez Santos",slug:"laura-rodriguez-santos",email:"laura@unex.es",position:null,institution:null},{id:"195143",title:"Dr.",name:"María I",middleName:null,surname:"Ramos Fuentes",fullName:"María I Ramos Fuentes",slug:"maria-i-ramos-fuentes",email:"miramos@unex.es",position:null,institution:null}]}},chapter:{id:"52200",slug:"eating-disorders-as-new-forms-of-addiction",signatures:"Francisco J. Vaz-Leal, María I. Ramos-Fuentes, Laura Rodríguez-\nSantos and M. Cristina Álvarez-Mateos",dateSubmitted:"April 9th 2016",dateReviewed:"August 12th 2016",datePrePublished:null,datePublished:"February 1st 2017",book:{id:"5372",title:"Eating Disorders",subtitle:"A Paradigm of the Biopsychosocial Model of Illness",fullTitle:"Eating Disorders - A Paradigm of the Biopsychosocial Model of Illness",slug:"eating-disorders-a-paradigm-of-the-biopsychosocial-model-of-illness",publishedDate:"February 1st 2017",bookSignature:"Ignacio Jauregui-Lobera",coverURL:"https://cdn.intechopen.com/books/images_new/5372.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"55769",title:"Prof.",name:"Ignacio",middleName:null,surname:"Jáuregui Lobera",slug:"ignacio-jauregui-lobera",fullName:"Ignacio Jáuregui Lobera"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"188555",title:"Prof.",name:"Francisco J.",middleName:null,surname:"Vaz-Leal",fullName:"Francisco J. Vaz-Leal",slug:"francisco-j.-vaz-leal",email:"fjvazleal@gmail.com",position:null,institution:null},{id:"188719",title:"Dr.",name:"María Cristina",middleName:null,surname:"Álvarez Mateos",fullName:"María Cristina Álvarez Mateos",slug:"maria-cristina-alvarez-mateos",email:"cristinaalvarezmateos@gmail.com",position:null,institution:null},{id:"195142",title:"Dr.",name:"Laura",middleName:null,surname:"Rodríguez Santos",fullName:"Laura Rodríguez Santos",slug:"laura-rodriguez-santos",email:"laura@unex.es",position:null,institution:null},{id:"195143",title:"Dr.",name:"María I",middleName:null,surname:"Ramos Fuentes",fullName:"María I Ramos Fuentes",slug:"maria-i-ramos-fuentes",email:"miramos@unex.es",position:null,institution:null}]},book:{id:"5372",title:"Eating Disorders",subtitle:"A Paradigm of the Biopsychosocial Model of Illness",fullTitle:"Eating Disorders - A Paradigm of the Biopsychosocial Model of Illness",slug:"eating-disorders-a-paradigm-of-the-biopsychosocial-model-of-illness",publishedDate:"February 1st 2017",bookSignature:"Ignacio Jauregui-Lobera",coverURL:"https://cdn.intechopen.com/books/images_new/5372.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"55769",title:"Prof.",name:"Ignacio",middleName:null,surname:"Jáuregui Lobera",slug:"ignacio-jauregui-lobera",fullName:"Ignacio Jáuregui Lobera"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"10188",leadTitle:null,title:"Orthotics and Prosthetics",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tDifferent prostheses and orthoses can be powerful devices for the standing, walking, and conservative treatment of a variety of pathologies that affected joint function, motor function, sensation/proprioception, and deformities such as upper limb disorders, lower limb disorders, spinal disorders, sports-related or overuse disorders. In prosthetics using, the aims are to restore normal walking the same to healthy subjects. The aims of treatment using orthotics are to restore normal performance, as well as to try to prevent further progression of the disease process affecting the body. This can be achieved by designing orthotics to correct or provide control and support.
\r\n\r\n\tThere are different types of prostheses. Recently more advanced prostheses were developed by many companies in this field. Orthoses are readily available in three forms, prefabricated off-the-shelf orthoses, custom made orthoses, and custom-molded orthoses manufactured from a model of the patient’s body. Each type of orthoses based on the designs and fabrication models have advantages and disadvantages.
\r\n\r\n\tIn this book based on the body sections, the specific prostheses and orthoses based on the biomechanical principle, function, and efficacy of them in the treatment and management of disorders and amputations will be explained.
",isbn:"978-1-83962-901-3",printIsbn:"978-1-83962-900-6",pdfIsbn:"978-1-83962-905-1",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"77fd1757d9fb545ad40d0dfa6e865d0b",bookSignature:"Dr. Mokhtar Arazpour",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10188.jpg",keywords:"Orthoses, Design Challenges, Efficiency of Orthoses, Braces, Biomechanical Principle of Orthoses, Future Directions of Orthoses, Conservative Management, Disability, Disorders, Disability, Disorders, Design of Orthoses",numberOfDownloads:209,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"July 1st 2020",dateEndSecondStepPublish:"October 5th 2020",dateEndThirdStepPublish:"December 4th 2020",dateEndFourthStepPublish:"February 22nd 2021",dateEndFifthStepPublish:"April 23rd 2021",remainingDaysToSecondStep:"5 months",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Dr. Mokhtar Arazpour has a Ph.D. in Orthotics and Prosthetics from the University of Social Welfare and Rehabilitation Sciences (USWR), Tehran, Iran. His research interests include lower-limb orthotics, osteoarthritis of knee and hand joints, design and construction of new lower-limb orthosis, and waling analysis.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"179731",title:"Dr.",name:"Mokhtar",middleName:null,surname:"Arazpour",slug:"mokhtar-arazpour",fullName:"Mokhtar Arazpour",profilePictureURL:"https://mts.intechopen.com/storage/users/179731/images/system/179731.jpg",biography:'Dr. Mokhtar Arazpour is an Assistant Professor, at Department of Orthotics and Prosthetics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. Dr. Arazpour has a PhD in Orthotics and Prosthetics from the University of Social Welfare and Rehabilitation Sciences (USWR), Tehran, Iran. He is Faculty member as Assistant Professor in the Department of Orthotics and Prosthetics since 2013. Dr. Mokhtar received his B.S. and M.Sc. and PhD in Orthotics and Prosthetics from USWR. His PhD thesis was "Design, Construction and Evaluation of the New Powered Gait Orthosis for Walking in Spinal Cord Injury Patients". Research interest of Dr. Mokhtar include lower limb orthotics, osteoarthritis of knee and hand joints, design and construction of new lower limb orthosis and waling analysis.',institutionString:"University of Social Welfare and Rehabilitation Sciences",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"University of Social Welfare and Rehabilitation Sciences",institutionURL:null,country:{name:"Iran"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:[{id:"74125",title:"Design and Fabrication of Prosthetic and Orthotic Product by 3D Printing",slug:"design-and-fabrication-of-prosthetic-and-orthotic-product-by-3d-printing",totalDownloads:78,totalCrossrefCites:0,authors:[null]},{id:"74805",title:"Audio-Vestibular Neurosensory Prosthetics: Origins, Expanding Indications and Future Directions",slug:"audio-vestibular-neurosensory-prosthetics-origins-expanding-indications-and-future-directions",totalDownloads:62,totalCrossrefCites:0,authors:[null]},{id:"74616",title:"Orthoses Development Using Modern Technologies",slug:"orthoses-development-using-modern-technologies",totalDownloads:50,totalCrossrefCites:0,authors:[null]},{id:"73928",title:"Impact of Self-Selected Customized Orthotics on Lower Limbs Biomechanics",slug:"impact-of-self-selected-customized-orthotics-on-lower-limbs-biomechanics",totalDownloads:23,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"247041",firstName:"Dolores",lastName:"Kuzelj",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/247041/images/7108_n.jpg",email:"dolores@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"24075",title:"Histopathology and Other Methods for Detection of Viral Hemorrhagic Septicemia (VHS) in Some Iranian Rainbow Trout Farms",doi:"10.5772/27771",slug:"histopathology-and-other-methods-for-detection-of-viral-hemorrhagic-septicemia-vhs-in-some-iranian-r",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/24075.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/24075",previewPdfUrl:"/chapter/pdf-preview/24075",totalDownloads:3038,totalViews:139,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,dateSubmitted:"February 22nd 2011",dateReviewed:"July 5th 2011",datePrePublished:null,datePublished:"November 21st 2011",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/24075",risUrl:"/chapter/ris/24075",book:{slug:"recent-advances-in-fish-farms"},signatures:"Adel Haghighi Khiabanian Asl",authors:[{id:"71469",title:"Dr",name:"Adel",middleName:null,surname:"Haghighi Khiabanian Asl",fullName:"Adel Haghighi Khiabanian Asl",slug:"adel-haghighi-khiabanian-asl",email:"dolmalid@yahoo.com",position:null,institution:null}],sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"612",title:"Recent Advances in Fish Farms",subtitle:null,fullTitle:"Recent Advances in Fish Farms",slug:"recent-advances-in-fish-farms",publishedDate:"November 21st 2011",bookSignature:"Faruk Aral and Zafer Doğu",coverURL:"https://cdn.intechopen.com/books/images_new/612.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"24070",title:"Evaluation of Aquaculture System Sustainability: A Methodology and Comparative Approaches",slug:"evaluation-of-aquaculture-system-sustainability-a-methodology-and-comparative-approaches",totalDownloads:1894,totalCrossrefCites:2,signatures:"J. Lazard, H. Rey-Valette, J. Aubin, S. Mathé, E. Chia, D. Caruso, O. Mikolasek, J.P. Blancheton, M. Legendre, A. Baruthio, F. René, P. Levang, J. Slembrouck, P. Morissens and O. Clément",authors:[{id:"67623",title:"Dr.",name:"Jerome",middleName:null,surname:"Lazard",fullName:"Jerome Lazard",slug:"jerome-lazard"}]},{id:"24071",title:"Geographic Information Systems as an Integration Tool for the Management of Mariculture in Paraty, Rio de Janeiro, Brazil",slug:"geographic-information-systems-as-an-integration-tool-for-the-management-of-mariculture-in-paraty-ri",totalDownloads:1664,totalCrossrefCites:0,signatures:"Julio Cesar Wasserman, Cristiano Figueiredo Lima and Maria Angélica Vergara Wasserman",authors:[{id:"65797",title:"Prof.",name:"Julio",middleName:null,surname:"Wasserman",fullName:"Julio Wasserman",slug:"julio-wasserman"},{id:"65807",title:"Dr.",name:"Cristiano",middleName:"Figueiredo",surname:"Lima",fullName:"Cristiano Lima",slug:"cristiano-lima"},{id:"128121",title:"Dr.",name:"Maria Angelica",middleName:"Vergara",surname:"Wasserman",fullName:"Maria Angelica Wasserman",slug:"maria-angelica-wasserman"}]},{id:"24072",title:"Nutrient Assimilation by Organisms on Artificial Reefs in a Fish Culture (Example of Hong Kong)",slug:"nutrient-assimilation-by-organisms-on-artificial-reefs-in-a-fish-culture-example-of-hong-kong-",totalDownloads:1957,totalCrossrefCites:0,signatures:"Paul K.S. Shin, Qinfeng Gao and Siu Gin Cheung",authors:[{id:"69769",title:"Dr.",name:"Paul",middleName:null,surname:"Shin",fullName:"Paul Shin",slug:"paul-shin"}]},{id:"24073",title:"Ejaculate Allocation and Sperm Competition in Alternative Reproductive Tactics of Salmon and Trout: Implications for Aquaculture",slug:"ejaculate-allocation-and-sperm-competition-in-alternative-reproductive-tactics-of-salmon-and-trout-i",totalDownloads:2278,totalCrossrefCites:1,signatures:"Tomislav Vladić",authors:[{id:"66067",title:"Dr.",name:"Tomislav",middleName:null,surname:"Vladic",fullName:"Tomislav Vladic",slug:"tomislav-vladic"}]},{id:"24074",title:"Embryonic and Larval Development of Freshwater Fish",slug:"embryonic-and-larval-development-of-freshwater-fish",totalDownloads:6871,totalCrossrefCites:0,signatures:"Faruk Aral, Erdinç Şahınöz and Zafer Doğu",authors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",fullName:"Faruk Aral",slug:"faruk-aral"},{id:"29132",title:"Dr.",name:"Zafer",middleName:null,surname:"Dogu",fullName:"Zafer Dogu",slug:"zafer-dogu"},{id:"39952",title:"Dr.",name:"Erdinc",middleName:null,surname:"Sahinoz",fullName:"Erdinc Sahinoz",slug:"erdinc-sahinoz"}]},{id:"24075",title:"Histopathology and Other Methods for Detection of Viral Hemorrhagic Septicemia (VHS) in Some Iranian Rainbow Trout Farms",slug:"histopathology-and-other-methods-for-detection-of-viral-hemorrhagic-septicemia-vhs-in-some-iranian-r",totalDownloads:3038,totalCrossrefCites:0,signatures:"Adel Haghighi Khiabanian Asl",authors:[{id:"71469",title:"Dr",name:"Adel",middleName:null,surname:"Haghighi Khiabanian Asl",fullName:"Adel Haghighi Khiabanian Asl",slug:"adel-haghighi-khiabanian-asl"}]},{id:"24076",title:"Stock Enhancement of Sturgeon Fishes in Iran",slug:"stock-enhancement-of-sturgeon-fishes-in-iran",totalDownloads:1697,totalCrossrefCites:0,signatures:"Hassan Salehi",authors:[{id:"76768",title:"Dr.",name:"Hassan",middleName:null,surname:"Salehi",fullName:"Hassan Salehi",slug:"hassan-salehi"}]},{id:"24077",title:"Environmental Effect of Using Polluted Water in New/Old Fish Farms",slug:"environmental-effect-of-using-polluted-water-in-new-old-fish-farms",totalDownloads:2669,totalCrossrefCites:1,signatures:"Y. Hamed, Sh. Salem, A. Ali and A. Sheshtawi",authors:[{id:"70745",title:"Dr.",name:"Yasser",middleName:null,surname:"Hamed",fullName:"Yasser Hamed",slug:"yasser-hamed"}]},{id:"24078",title:"Photobacterium damselae subsp. damselae, an Emerging Pathogen Affecting New Cultured Marine Fish Species in Southern Spain",slug:"photobacterium-damselae-subsp-damselae-an-emerging-pathogen-affecting-new-cultured-marine-fish-speci",totalDownloads:3426,totalCrossrefCites:16,signatures:"A. Labella, C. Berbel, M. Manchado, D. Castro and J.J. Borrego",authors:[{id:"67855",title:"Prof.",name:"Juan J.",middleName:null,surname:"Borrego",fullName:"Juan J. Borrego",slug:"juan-j.-borrego"},{id:"71146",title:"Dr.",name:"Alejandro",middleName:null,surname:"Labella",fullName:"Alejandro Labella",slug:"alejandro-labella"},{id:"71148",title:"Dr.",name:"Concepcion",middleName:null,surname:"Berbel",fullName:"Concepcion Berbel",slug:"concepcion-berbel"},{id:"71149",title:"Dr.",name:"Manuel",middleName:null,surname:"Manchado",fullName:"Manuel Manchado",slug:"manuel-manchado"},{id:"71151",title:"Dr.",name:"Dolores",middleName:null,surname:"Castro",fullName:"Dolores Castro",slug:"dolores-castro"}]},{id:"24079",title:"Bacteria Isolated From Diseased Wild and Farmed Marine Fish in Greece",slug:"bacteria-isolated-from-diseased-wild-and-farmed-marine-fish-in-greece",totalDownloads:2496,totalCrossrefCites:6,signatures:"Mary Yiagnisis and Fotini Athanassopoulou",authors:[{id:"71057",title:"Dr.",name:"Mary",middleName:null,surname:"Yiagnisis",fullName:"Mary Yiagnisis",slug:"mary-yiagnisis"}]},{id:"24080",title:"The Immune System Drugs in Fish: Immune Function, Immunoassay, Drugs",slug:"the-immune-system-drugs-in-fish-immune-function-immunoassay-drugs",totalDownloads:5851,totalCrossrefCites:5,signatures:"Cavit Kum and Selim Sekkin",authors:[{id:"68075",title:"Dr.",name:"Cavit",middleName:null,surname:"Kum",fullName:"Cavit Kum",slug:"cavit-kum"}]},{id:"24081",title:"Antibacterial Drugs in Fish Farms: Application and Its Effects",slug:"antibacterial-drugs-in-fish-farms-application-and-its-effects",totalDownloads:6411,totalCrossrefCites:7,signatures:"Selim Sekkin and Cavit Kum",authors:[{id:"68279",title:"Dr.",name:"Selim",middleName:null,surname:"Sekkin",fullName:"Selim Sekkin",slug:"selim-sekkin"}]}]},relatedBooks:[{type:"book",id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,isOpenForSubmission:!1,hash:"13aaddf5fdbbc78387e77a7da2388bf6",slug:"animal-reproduction-in-veterinary-medicine",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"70381",title:"Physiological and Clinical Aspects of the Endocrinology of the Estrous Cycle and Pregnancy in Mares",slug:"physiological-and-clinical-aspects-of-the-endocrinology-of-the-estrous-cycle-and-pregnancy-in-mares",signatures:"Katy Satué and Juan Carlos Gardon",authors:[{id:"125292",title:"Dr.",name:"Katy",middleName:null,surname:"Satué Ambrojo",fullName:"Katy Satué Ambrojo",slug:"katy-satue-ambrojo"},{id:"251314",title:"Dr.",name:"Juan Carlos",middleName:null,surname:"Gardón",fullName:"Juan Carlos Gardón",slug:"juan-carlos-gardon"}]},{id:"71105",title:"Understanding Sow Sexual Behavior and the Application of the Boar Pheromone to Stimulate Sow Reproduction",slug:"understanding-sow-sexual-behavior-and-the-application-of-the-boar-pheromone-to-stimulate-sow-reprodu",signatures:"John J. McGlone, Edgar O. Aviles-Rosa, Courtney Archer, Meyer M. Wilson, Karlee D. Jones, Elaina M. Matthews, Amanda A. Gonzalez and Erica Reyes",authors:[{id:"311962",title:"Prof.",name:"John",middleName:null,surname:"McGlone",fullName:"John McGlone",slug:"john-mcglone"},{id:"315592",title:"Dr.",name:"Edgar",middleName:"Omar",surname:"Aviles-Rosa",fullName:"Edgar Aviles-Rosa",slug:"edgar-aviles-rosa"},{id:"315595",title:"B.Sc.",name:"Courtney",middleName:null,surname:"Archer",fullName:"Courtney Archer",slug:"courtney-archer"},{id:"315596",title:"Ms.",name:"Meyer",middleName:null,surname:"Wilson",fullName:"Meyer Wilson",slug:"meyer-wilson"},{id:"315597",title:"Ms.",name:"Karlee",middleName:null,surname:"Jones",fullName:"Karlee Jones",slug:"karlee-jones"},{id:"315598",title:"Ms.",name:"Elaina",middleName:null,surname:"Mathews",fullName:"Elaina Mathews",slug:"elaina-mathews"},{id:"315599",title:"Ms.",name:"Erica",middleName:"Leighann",surname:"Reyes",fullName:"Erica Reyes",slug:"erica-reyes"},{id:"315600",title:"MSc.",name:"Amanda",middleName:null,surname:"Gonzalez",fullName:"Amanda Gonzalez",slug:"amanda-gonzalez"}]},{id:"73979",title:"Troubled Process of Parturition of the Domestic Pig",slug:"troubled-process-of-parturition-of-the-domestic-pig",signatures:"Claudio Oliviero and Olli Peltoniemi",authors:[{id:"45491",title:"Prof.",name:"Olli",middleName:null,surname:"Peltoniemi",fullName:"Olli Peltoniemi",slug:"olli-peltoniemi"},{id:"45504",title:"Dr.",name:"Claudio",middleName:null,surname:"Oliviero",fullName:"Claudio Oliviero",slug:"claudio-oliviero"}]},{id:"73371",title:"Reproduction in Small Ruminants (Goats)",slug:"reproduction-in-small-ruminants-goats-",signatures:"Fernando Sánchez Dávila and Gerardo Pérez Muñoz",authors:[{id:"201830",title:"Dr.",name:"Fernando",middleName:"Sanchez",surname:"Davila",fullName:"Fernando Davila",slug:"fernando-davila"},{id:"327566",title:"MSc.",name:"Gerardo",middleName:null,surname:"Perez-Muñoz",fullName:"Gerardo Perez-Muñoz",slug:"gerardo-perez-munoz"}]},{id:"71297",title:"Tools and Protocols for Managing Hyperprolific Sows at Parturition: Optimizing Piglet Survival and Sows’ Reproductive Health",slug:"tools-and-protocols-for-managing-hyperprolific-sows-at-parturition-optimizing-piglet-survival-and-so",signatures:"Stefan Björkman and Alexander Grahofer",authors:[{id:"311550",title:"Ph.D.",name:"Stefan",middleName:null,surname:"Björkman",fullName:"Stefan Björkman",slug:"stefan-bjorkman"},{id:"317576",title:"Dr.",name:"Alexander",middleName:null,surname:"Grahofer",fullName:"Alexander Grahofer",slug:"alexander-grahofer"}]},{id:"72063",title:"The Lidia Breed: Management and Medicine",slug:"the-lidia-breed-management-and-medicine",signatures:"Juan Manuel Lomillos and Marta Elena Alonso",authors:[{id:"312934",title:"Ph.D.",name:"Juan Manuel",middleName:null,surname:"Lomillos Perez",fullName:"Juan Manuel Lomillos Perez",slug:"juan-manuel-lomillos-perez"},{id:"316830",title:"Dr.",name:"Marta Elena",middleName:null,surname:"Alonso",fullName:"Marta Elena Alonso",slug:"marta-elena-alonso"}]},{id:"70760",title:"Induction and Synchronization of Estrus",slug:"induction-and-synchronization-of-estrus",signatures:"Prasanna Pal and Mohammad Rayees Dar",authors:[{id:"299126",title:"Dr.",name:"Mohammad Rayees",middleName:null,surname:"Dar",fullName:"Mohammad Rayees Dar",slug:"mohammad-rayees-dar"},{id:"311663",title:"Dr.",name:"Prasanna",middleName:null,surname:"Pal",fullName:"Prasanna Pal",slug:"prasanna-pal"}]},{id:"73116",title:"Bovine Mastitis: Part I",slug:"bovine-mastitis-part-i",signatures:"Oudessa Kerro Dego",authors:[{id:"283019",title:"Dr.",name:"Oudessa",middleName:null,surname:"Kerro Dego",fullName:"Oudessa Kerro Dego",slug:"oudessa-kerro-dego"}]},{id:"73077",title:"Control and Prevention of Mastitis: Part Two",slug:"control-and-prevention-of-mastitis-part-two",signatures:"Oudessa Kerro Dego",authors:[{id:"283019",title:"Dr.",name:"Oudessa",middleName:null,surname:"Kerro Dego",fullName:"Oudessa Kerro Dego",slug:"oudessa-kerro-dego"}]},{id:"73658",title:"Current Status of Antimicrobial Resistance and Prospect for New Vaccines against Major Bacterial Bovine Mastitis Pathogens",slug:"current-status-of-antimicrobial-resistance-and-prospect-for-new-vaccines-against-major-bacterial-bov",signatures:"Oudessa Kerro Dego",authors:[{id:"283019",title:"Dr.",name:"Oudessa",middleName:null,surname:"Kerro Dego",fullName:"Oudessa Kerro Dego",slug:"oudessa-kerro-dego"}]},{id:"73504",title:"Calf-Sex Influence in Bovine Milk Production",slug:"calf-sex-influence-in-bovine-milk-production",signatures:"Miguel Quaresma and R. Payan-Carreira",authors:[{id:"38652",title:"Dr.",name:"Rita",middleName:null,surname:"Payan-Carreira",fullName:"Rita Payan-Carreira",slug:"rita-payan-carreira"},{id:"309250",title:"Dr.",name:"Miguel",middleName:null,surname:"Quaresma",fullName:"Miguel Quaresma",slug:"miguel-quaresma"}]},{id:"72504",title:"Reproductive Toxicity of Insecticides",slug:"reproductive-toxicity-of-insecticides",signatures:"Mehtap Kara and Ezgi Öztaş",authors:[{id:"288339",title:"Ph.D.",name:"Mehtap",middleName:null,surname:"Kara",fullName:"Mehtap Kara",slug:"mehtap-kara"},{id:"320434",title:"Dr.",name:"Ezgi",middleName:null,surname:"Öztaş",fullName:"Ezgi Öztaş",slug:"ezgi-oztas"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"68399",title:"Sexual and Psychoemotional Disorders in Male Patients Treated for Prostate Carcinoma",doi:"10.5772/intechopen.87208",slug:"sexual-and-psychoemotional-disorders-in-male-patients-treated-for-prostate-carcinoma",body:'Prostate carcinoma (PCa) is one of the most frequent malignant cancers in the male population. In terms of incidence, it is second only to lung cancer. Treatment of prostate carcinoma includes surgical procedures, radiotherapy, chemotherapy, and hormone therapy, and all these procedures have an adverse impact on the sexual functioning of men. Erectile disorders, loss of sex drive, and difficulty achieving orgasm are the most frequent problems in the course of disease and its treatment [1, 2]. The existing studies show that few men with sexual dysfunctions and on cancer treatment seek the help of a specialist to effectively eliminate such problems [3]. Other studies show that this population of patients frequently experiences, as a result of changes in the sexual functioning, fear, anxiety, and depression as well as loss of male identity [4]. Therefore, psychological care and social support (including their closest family and friends) are increasingly considered an important component of many chronic diseases. At the same time, studies suggest that men who find no emotional support in their social environment are more exposed to depression and more seldom achieve positive mental well-being [5]. Additionally, it was demonstrated that specialist (psychological) and social support are associated with significantly reduced mental stress and general improvement of the quality of life in the population of men with prostate carcinoma.
The study’s patients were recruited at the Oncological Hospital in Wieliszew, Poland,between September 2016 to December 2017. The study was performed 166 male patients diagnosed with prostate cancer. The study included men who gave informed, written consent to participate. In the study was used two standardized questionnaire: EORTC QLQ-C30 (version 3.0) and QLQ-PR25 for patients with prostate cancer, developed by the European Quality of Life Group. These questionnaires are used to research the summary sense of health and evaluation of performance in various dimensions (physical, emotional and social) and typical symptoms of prostate cancer.
The Ethical Committee consent for the presented research is not required. According to the statement of the Ethical Committee of the Medical University of Warsaw: “The Committee does not provide opinions on surveys, retrospective studies, or other non-invasive research” (Detailed information and templates of documents of Ethics Committee of Medical University of Warsaw (Accessed 2016-10-01):
The study included 166 men. The mean age of participants was 67.66 ± 7.25 (range: 51–84 years). The main part of population taking part in the study comprised people aged 65–69 years (37.35%). The majority (68.7%) of patients, during the study, were undergoing the treatment. The treatment analysis revealed that 66% of the participants subjected to radiotherapy. Smaller numbers were found for the remaining therapy: 16.9% hormonal therapy, 2.38% surgery (4.8%), and 3.6% chemotherapy. The proportion of patients was treated with combined therapies: radiotherapy + surgery (8.33%), radiation + hormonal therapy (6.03%), and surgery + hormonal + chemotherapy (2.41%). The characteristics of the patients are shown in Table 1.
No correlation was found between the study variable and the health status or quality of life score or the age of patients. However, feeling tense may be affected by the type of treatment administered to the patients (Chi2 = 94.15, p = 0.0000; R = 0.21, p > 0.05). The results of statistical analysis show that the greatest number of men who declared that they did not feel tense during the last week underwent radiotherapy (58.82%) or radiotherapy and surgical treatment (57.14%). On the other hand, all the patients who received surgical treatment, chemotherapy, and hormone therapy indicated that they felt very tense. A similar correlation was shown in relation to the stage of cancer treatment (Chi2 = 19.73, p = 0.00310; R = −0.00, p > 0.05).
Feeling worried also depends on the stage of cancer treatment (Chi2 = 21.67, p = 0.00139; R = 0.20, p > 0.05). Posttreatment patients significantly more often indicated that they did not worry during the last week (56.25% of the group), while patients waiting for treatment more often declared to feel worried or very worried (40% of the group in total). Similarly to the question about feeling tense, the results show that feeling worried affected all the patients undergoing surgical treatment, chemotherapy, and hormone therapy. Patients receiving radiotherapy (27.45% of the group) or both radiotherapy and surgical treatment (28.57%) (Chi2 = 69.06, p = 0.0000; R = 0.13, p > 0.05) most often indicated that they did not feel worried. However, no correlation was found between feeling worried and the patients’ age (p > 0.05).
The impact of health status on patients feeling worried was also insignificant (Chi2 = 44.87, p = 0.00043; R = −0.04, p > 0.05), although it could be observed that patients with a greater health status score more rarely indicated that they felt worried. A similar correlation was observed with regard to the quality of life score (Chi2 = 43.38, p = 0.00071; R = −0.11, p > 0.05).
None of the patients who received cancer treatment declared to be very or significantly irritable. However, these responses were indicated by 40% of the patients waiting for treatment (Chi2 = 16.24, p = 0.01251; R = −0.03, p > 0.05). The least irritability were experienced by patients undergoing radiotherapy or surgical treatment, the greatest irritability—by patients receiving surgical treatment, chemotherapy, and hormone therapy (Chi2 = 69.05, p = 0.0000; R = 0.06, p > 0.05). On the other hand, no correlation was found between feeling irritable and the patients’ age, health status, or quality of life score (p > 0.05 for all the cases).
Even though no correlation was found between the age or the quality of life score and feeling depressed (p > 0.05), a statistical analysis of the study results showed that feeling depressed may depend on the patient’s health status (Chi2 = 33.34, p = 0.01517; R = −0.36, p = 0.00681). Patients with a lower health status score much more often declared that they felt depressed during the last week.
As with the above-described correlations, feeling depressed is also correlated (although weakly) with the stage of the patient’s treatment (Chi2 = 13.11, p = 0.04122; R = 0.06, p > 0.05) and the type of treatment (Chi2 = 67.37, p = 0.0000; R = 0.11, p > 0.05). No depression was most often indicated by patients who underwent cancer treatment (56.25% of this group), radiotherapy (45.10%), or both radiotherapy and surgery (42.86%).
The greatest difficulties in remembering were indicated by pretreatment patients (30% of responses “to a significant degree” and “very much” in this group of patients compared to 7% of the patients on treatment and 0% of the posttreatment patients) (Chi2 = 19.25, p = 0.00376; R = −0.07, p > 0.05) and those receiving surgical treatment, hormone therapy, and chemotherapy (100% of the group) (Chi2 = 97.20, p = 0.0000; R = 0.08, p > 0.05). Additionally, a strong correlation was found between difficulties in remembering and health status score (Chi2 = 34.89, p = 0.00976; R = −0.45, p = 0.0000). The higher health status score is correlated with an absence of difficulties in remembering or only slight difficulties in remembering. Serious and very serious difficulties in remembering were indicated only by the patients with a health status score less than 5. A similar correlation exists with regard to the quality of life score. Patients with the lowest quality of life score did not indicate any considerable or significant problems in remembering. Patients who declared frequent problems in remembering had a lower quality of life score (Chi2 = 32.30, p = 0.02024; R = −0.26, p = 0.00071). However, no correlation was found between difficulties in remembering and the patients’ age (p > 0.05) (Tables 2 and 3).
Characteristics of the patients in the survey | Number of patients (N = 166 (100%)) |
---|---|
Age | |
<54 | 2 (1.2) |
55–59 | 16 (9.6) |
60–64 | 26 (15.7) |
65–69 | 62 (37.3) |
70–74 | 24 (14.5) |
75–79 | 24 (14.5) |
>80 | 12 (7.2) |
Stage of oncology treatment | |
Before treatment | 20 (12) |
During the course of treatment | 114 (68.7) |
After treatment | 32 (19.3) |
Type of oncology treatmenta | |
Surgery | 8 (4.8) |
Radiotherapy | 110 (66) |
Hormonal therapy | 28 (16.9) |
Chemotherapy | 6 (3.6) |
I do not know | 20 (12) |
Characteristics of the group of patients participating in the survey.
The question with multiple answers.
Emotional problems | Question no.a | Number of patients (N = 166) N (%) | |||
---|---|---|---|---|---|
Not at all | A little | Quite a bit | Very much | ||
Feeling circuit | 21 | 86 (51.8) | 72 (43.4) | 4 (2.4) | 4 (2.4) |
Feeling worried | 22 | 40 (24.1) | 98 (59) | 22 (13.3) | 6 (3.6) |
The feeling of annoyance | 23 | 68 (40.9) | 70 (42.2) | 22 (13.3) | 6 (3.6) |
Feeling depressed | 24 | 70 (42.2) | 72 (43.4) | 18 (10.8) | 6 (3.6) |
Difficulty in remembering | 25 | 84 (50.6) | 68 (41.0) | 10 (6) | 4 (2.4) |
Emotional problems of the patients.
Number of issues in accordance with the questionnaire QLQ-C30.
Emotional problems | Question no.a | Quality of life | |
---|---|---|---|
p-value | R-Spearmanb | ||
Feeling circuit | 21 | 0.727 | — |
Feeling worried | 22 | 0.000 | — |
The feeling of annoyance | 23 | 0.353 | — |
Feeling depressed | 24 | 0.174 | — |
Difficulty in remembering | 25 | 0.020 | −0.364 |
Emotional problems of the patients and felt the quality of life.
Number of issues in accordance with the questionnaire QLQ-C30.
Significant correlation p < 0.05.
Among the study patients, 12% of them frequently passed urine during the day. This problem has a significant impact on the quality of life of the patients (Chi2 = 30.86, p = 0.02988; R = −0.24, p = 0.02967). Patients with no problems with frequent urination during the day had a higher quality of life score compared to patients who had to urinate very frequently during the day. Similar but significantly weaker correlation was identified between the quality of life score and frequent nighttime urination (Chi2 = 33.42, p = 0.01484; R = −0.11, p > 0.05) or the quality of life score and the need to hurry into the toilet before passing urine (Chi2 = 33.83, p = 0.01321; R = 0.05, p > 0.05).
Over 60% of the patients indicated that having to get up at night to urinate affected their night’s rest. This problem had a strong impact on how the patients assessed their quality of life (Chi2 = 54.09, p = 0.0000; R = −0.52, p = 0.0000). The quality of life score was also affected by problems related to going out of the house due to the fact that the patients had to be close to a toilet. Problems with involuntary release of urine were indicated by nearly half of the patients, and 17% of the patients considered this problem to be considerable or significant. This group of patients usually has a lower quality of life score, even though this correlation is not strong (Chi2 = 43.87, p = 0.00060; R = −0.21, p > 0.05). Nearly 50% of the patients declared to have painful urination; however, no correlation was found between pain and the quality of life score (p > 0.05). Among the study patients, 32.53% of them use protection products against urinary incontinence. Using this type of protection was considered a nuisance only by 40% of the patients and affected how they perceived their quality of life (Chi2 = 55.22, p = 0.00001; R = −0.23, p = 0.03563). Generally, limitations related to everyday functioning due to urination problems were indicated by nearly 40% of men. This effect was considered significant or highly significant by 12% of the patients. However, the correlation between the limitation of everyday activities and the quality of life score is insignificant (Chi2 = 38.50, p = 0.00332; R = 0.17, p > 0.05). Detailed results are given in Tables 4 and 5.
Problems with urination | Question no.a | Number of patients (N = 166) N (%) | |||
---|---|---|---|---|---|
Not at all | A little | Quite a bit | Very much | ||
Frequent urination during the day | 31 | 14 (8.4) | 76 (45.8) | 56 (33.7) | 20 (12.1) |
Frequent urination during the night | 32 | 22 (13.3) | 82 (49.4) | 44 (26.5) | 18 (10.8) |
The need to accelerate the toilet before urinating | 33 | 48 (28.9) | 64 (38.6) | 28 (16.9) | 26 (15.7) |
The impact of waking up at night to night stay | 34 | 56 (33.7) | 64 (38.6) | 36 (21.7) | 10 (6) |
Problems with leaving home because of the frequent need to use the toilet | 35 | 80 (48.2) | 60 (36.1) | 14 (8.43) | 12 (7.2) |
Involuntary leakage of urine | 36 | 86 (51.81) | 52 (31.33) | 18 (10.8) | 10 (6) |
Pain when urinating | 37 | 84 (50.6) | 70 (42.2) | 6 (3.6) | 6 (3.6) |
Problems with wearing protection against incontinence | 38b | 32 (59.3) | 16 (29.6) | 6 (3.6) | 0 (0) |
Limitation of daily activities by problems with urination | 39 | 102 (61.5) | 44 (26.5) | 14 (8.4) | 6 (3.6) |
Problems with urinating in the group of patients studied.
Number of issues in accordance with the questionnaire QLQ-C30.
Question applies only to patients wearing protection against urinary incontinence (N = 54).
Problems with urination | Question no.a | Quality of life | |
---|---|---|---|
p-value | R-Spearmanb | ||
Frequent urination during the day | 31 | 0.029 | 0.239 |
Frequent urination during the night | 32 | 0.014 | — |
The need to accelerate the toilet before urinating | 33 | 0.013 | — |
The impact of waking up at night to night stay | 34 | 0.000 | −0.518 |
Problems with leaving home because of the frequent need to use the toilet | 35 | 0.002 | −0.314 |
Involuntary leakage of urine | 36 | 0.000 | — |
Pain when urinating | 37 | 0.060 | — |
Problems with wearing protection against incontinence | 38c | 0.000 | −0.231 |
Limitation of daily activities by problems with urination | 39 | 0.003 | — |
Problems with urination and the evaluation of the quality of life for patients.
Number of issues in accordance with the questionnaire QLQ-C30.
Demonstrated statistically significant correlations only; p < 0.05.
Question applies only to patients wearing protection against urinary incontinence (N = 54).
Nearly 60% of the patients indicated that they experienced a sense of loss of manhood due to the disease or its treatment. Younger patients more often declared a strong or very strong sense of loss of manhood (100% of patients under the age of 54 years, 62.5% of patients aged 55 to 59 compared to 50% of patients aged 75–79 or 16.67% of patients over the age of 80 years) (Chi2 = 40.61, p = 0.00172; R = 0.09, p > 0.05). A sense of loss of manhood was mostly declared by the posttreatment patients or the patients on cancer treatment (the responses “very strong” and “strong” were given by 57.89 and 75% compared to 30% of patients waiting for treatment) (Chi2 = 14.74, p = 0.02230; R = 0.15, p > 0.05). The type of treatment had no impact on a sense of loss of manhood (p > 0.05). Nearly half of the patients had no interest in sexual life during the last 4 weeks (45.8%). No interest in having sex was mostly indicated by elderly patients over 70 years of age. None of the patients under 60 years of age selected the response “none” (Chi2 = 41.22, p = 0.00142; R = 0.08, p > 0.05). As regards the stage of oncological treatment, 43.75% of the posttreatment patients and 52.63% of the patients on treatment had no interest in sex. Among the patients waiting for treatment, it was 10% (Chi2 = 26.89, p = 0.00015; R = 0.18, p > 0.05). Patients undergoing radiotherapy or radiotherapy and hormone therapy showed least interest in sexual life, while patients undergoing surgical treatment or surgical treatment, chemotherapy, and hormone therapy—greatest interest in sexual life (Chi2 = 55.75, p = 0.00001; R = 0.09, p > 0.05). Nearly 60% of the patients were not sexually active during the last 4 months, and there is no correlation between the level of sexual activity and the patient’s age (p > 0.05). The posttreatment patients and those on treatment were least sexually active (the response “none” was indicated by 64.91% and 50% of the patients in these groups, respectively). Among the patients waiting for treatment, 30% of the patients declared lack of sexual activities (Chi2 = 20.32, p = 0.00234; R = 0.12, p > 0.05). Based on an analysis of the type of treatment, it can be shown that patients who underwent surgical treatment or chemotherapy and hormone therapy were characterized by greatest sexual activity (100% in both cases). In the other treatment categories, the percentage of sexually active men was about 40% (Chi2 = 46.43, p = 0.00026; R = 0.04, p > 0.05).
Among the patients who were sexually active during the last 4 months, 37% of them were satisfied or very satisfied with their sexual life. High or very high satisfaction with sexual life was indicated by 50% of the patients prior to cancer treatment, 12.5% of the posttreatment patients, and 7% of the patients on treatment (Chi2 = 23.89, p = 0.00239; R = 0.33, p = 0.00228). The type of treatment also affected satisfaction with sexual life (Chi2 = 76.52, p = 0.0000; R = 0.05, p > 0.05). Patients undergoing surgical procedures, hormone therapy, and chemotherapy were very satisfied with their sexual life, while patients undergoing only surgical procedures or surgical procedures combined with radiotherapy declared low or no satisfaction with their sexual life. The patient’s age has no effect on his satisfaction with sexual life (p > 0.05).
Difficulties with achieving or maintaining erection were declared by 73.3% of the sexually active patients, regardless of their age (p > 0.05). Significant or considerable difficulties were most often indicated by patients on cancer treatment (30% of the patients) (Chi2 = 16.71, p = 0.03328; R = 0.29, p = 0.00839) or patients undergoing radiotherapy (43.33%) (Chi2 = 61.98, p = 0.00003; R = −0.01, p > 0.05).
Difficulties with ejaculation were declared by 66.7% of the sexually active patients, even though these problems are not related to the patients’ age (p > 0.05). Problems with ejaculation were least frequent among patients prior to cancer treatment (50%), while all the posttreatment patients reported having such difficulties (Chi2 = 34.44, p = 0.00003 R = 0.27, p = 0.01530). Patients who received surgical treatment, hormone therapy, or both radiotherapy and hormone therapy had no difficulties with ejaculation (Chi2 = 45.58, p = 0.00496; R = 0.04, p > 0.05).
A feeling of embarrassment during intimate contact was indicated only by 56.7% of the sexually active patients. The above variable was not age-dependent (p > 0.05). However, a feeling of embarrassment was correlated with the stage of cancer treatment (Chi2 = 16.85, p = 0.03164; R = 0.30, p = 0.00526) and the type of treatment (Chi2 = 40.05, p = 0.02111; R = 0.00, p > 0.05). Embarrassment during sexual contact was not experienced by pretreatment patients, patients receiving surgical treatment, hormone therapy or radiotherapy in combination with hormone therapy.
It should be pointed out that none of the discussed aspects of sexual activity, in relation to all the patients or only those sexually active during the last 4 months, had no impact on the quality of life score (p > 0.05 for all cases). The above results are shown in Tables 6 and 7.
Sexual activity | Question no.a | Number of patients (N = 166) N (%) | |||
---|---|---|---|---|---|
Not at all | A little | Quite a bit | Very much | ||
Feeling perdition masculinity | 49 | 26 (15.7) | 44 (26.5) | 40 (24.1) | 56 (33.7) |
The interest in sexual intercourse | 50 | 72 (45.8) | 48 (28.9) | 20 (12.1) | 22 (13.3) |
The degree of sexual activity | 51 | 96 (57.8) | 34 (20.5) | 18 (10.8) | 18 (10.8) |
Satisfaction with sexual intercourse | 52b | 28 (46.8) | 10 (16.7) | 8 (13.3) | 14 (23.3) |
Difficulty getting or maintaining an erection | 53b | 16 (26.7) | 12 (20.0) | 14 (23.3) | 18 (30.0) |
Difficulties with ejaculation | 54b | 20 (33.3) | 12 (20.0) | 6 (10.0) | 22 (36.7) |
The feeling of embarrassment during intimacy | 55b | 26 (43.3) | 4 (6.7) | 12 (20.0) | 18 (30.0) |
Sexual activity patients.
Number of issues in accordance with the questionnaire QLQ-C30.
Question applies only to patients who are sexually active within the last 4 weeks (N = 60).
Problems with urination | Question no.a | Quality of life | |
---|---|---|---|
p-value | R-Spearmanb | ||
Feeling perdition masculinity | 49 | 0.134 | — |
The interest in sexual intercourse | 50 | 0.420 | — |
The degree of sexual activity | 51 | 0.384 | — |
Satisfaction with sexual intercourse | 52c | 0.509 | — |
Difficulty getting or maintaining an erection | 53c | 0.142 | — |
Difficulties with ejaculation | 54c | 0.361 | — |
The feeling of embarrassment during intimacy | 55c | 0.585 | — |
Sexual activity and quality of life of the patients.
Number of issues in accordance with the questionnaire QLQ-C30.
Demonstrated statistically significant correlations only; p < 0.05.
Question applies only to patients who are sexually active within the last 4 weeks (N = 60).
Sexuality is an important aspect of human life, and emotions related to sexual activity influence mental well-being, relationship, or how we see ourselves. Sexual function disorders (e.g., erectile dysfunction) caused by prostate carcinoma significantly reduces the quality of life of men [6, 7, 8]. Cancer treatment is also related to reduced sex drive and penile dysfunction manifesting itself through, for example, reduced ability to have an orgasm, erectile disorders, or urinary incontinence [9, 10]. The above changes in sexual functions are also related to anxiety and depression, challenges in everyday life, and disrupted intimate relations with the patient’s partner [11, 12, 13, 14]. However, other studies indicated that many patients with prostate carcinoma suffer at a later stage from complications in the course of disease and its treatment [15, 16].
On the other hand, feeling worried also depends on the stage of cancer treatment. Patients waiting for treatment more often declared to be worried (to a considerable or significant extent) than posttreatment patients. At the same time, all the patients who received surgical treatment, chemotherapy, and hormone therapy indicated that they felt worried. No fatigue was most often indicated by patients receiving radiotherapy or both radiotherapy and surgical treatment. However, health status also had an insignificant impact on patients feeling worried, even though patients with a greater quality of life score more rarely declared that they felt worried. Other studies suggest that hot flushes were strongly associated with insomnia and they caused depression particularly in the group of elderly men receiving hormone therapy [17, 18, 19]. However, Yang et al. [20] determined that physical condition of cancer patients was closely related to the fatigue index and it was also the major factor affecting the quality of life of patients. Other studies showed that regular monitoring of fatigue and its elimination could improve physical condition of patients and therefore improve their quality of life [21, 22]. It is well documented in the literature that all types of cancer treatment, and especially chemotherapy, are associated with side effects such as fatigue, depression, pain, and many other problems [23, 24, 25]. Urination problems during the day had a significant negative impact on the quality of life of patients. A similar but significantly weaker correlation was identified between the quality of life score and frequent nighttime urination or the quality of life score and the need to hurry into the toilet before passing urine. At the same time, having to get up frequently at night to urinate affects the night’s rest and has a strong impact on how patients perceive their quality of life. However, pain during urination was declared by half of the patients, and no correlation was found between pain and the quality of life score. Vogl et al. [26] showed that an insignificant number of men undergoing cancer treatment had certain difficulties passing urine which were reversible over time. However, Arscott et al. [27] demonstrated that urinary tract symptoms are frequently associated with sexual disorders after surgical treatment and radiotherapy.
An analysis of the sexual activity of the study patients showed that younger men more often indicated a strong or very strong sense of loss of manhood due to the disease or its treatment. A sense of loss of manhood was mostly declared by posttreatment patients or patients on cancer treatment. The type of treatment had no impact on a sense of loss of manhood (p > 0.05). In one of their studies, Zaider et al. [1]found that 1/3 of the male patients lost an important aspect of their manhood as a side effect of disease treatment, which proved to be a significant obstacle to their sexuality. O′ Shaughnessy et al. [2] determined that the affected patients may not be fully aware of their sexual losses. In another study, an inability to perform sexually by men diagnosed with a chronic disease was described as a source of suffering [28, 29]. Harrington et al. [30] argued that a body image is an important aspect of human quality of life, especially in patients diagnosed with cancer. On the other hand, the loss of sexual functions in posttreatment patients may undermine their concept of manhood [31, 32].
Patients undergoing surgical treatment or chemotherapy and hormone therapy showed the least interest in sexual life. On the other hand, there is no correlation between the level of sexual activity and the patients’ age (p > 0.05). Posttreatment patients and patients on treatment were least sexually active. Additionally, taking into account the type of treatment, patients receiving surgical treatment or chemotherapy and hormone therapy were characterized by greatest sexual activity. Another study demonstrated that unwillingness to meet people or have sex is more common among men treated for cancer and it is most likely best observable in men with prostate carcinoma who receive hormone therapy. The study at hand showed that more than 95% of men treated with this method reported subjective sex drive disorders [6]. However, DiBlasio et al. [13] demonstrated that more than 95% of men receiving hormone therapy reported libido and sex drive disorders. The loss of libido is frequently observable in patients with Hodgkin disease (Hodgkin lymphoma), where more than 40% of men reported this side effect [14]. The loss of libido was also observable in patients with hematologic cancers [15, 16]. Different results were obtained by Olsson et al. [33] who argued that low libido may originate from fatigue and/or feeling unwell. Furthermore, this condition may be associated with the stage of disease and intensive cancer therapy.
Our study showed that among sexually active men, pretreatment and posttreatment patients as well as patients on cancer treatment were satisfied or very satisfied with their sexual life. The level of satisfaction with sexual life was also affected by the type of treatment, while the patients’ age had no effect on their satisfaction with sexual life (p > 0.05). Given that good mental well-being depends on many factors, it cannot be stated without ambiguity that men can achieve sexual satisfaction only through a successful sexual intercourse. However, for men with chronic erectile disorders, inability to achieve penetration may be a source of considerable difficulties and frustration. For example, couples open to changes and willing to cooperate were able to adapt to the needs of the affected partner and to accept the side effects of cancer treatment [34, 35, 36].
However, our studies showed that men receiving treatment or radiotherapy have considerable or major difficulties in achieving or maintaining erection. Other study [3] shown that erectile disorders were observed in 77% of men treated for prostate carcinoma who underwent radical prostatectomy and in 60% of patients receiving radiotherapy. It was also observed that post-radiotherapy erectile disorders were usually delayed (1 or 2 years after therapy) in contrast to a quick response achieved in a group of patients immediately after surgical treatment [28]. Erectile disorders were also observed in other populations, for example, in patients treated for anal diseases or rectal and testicular cancer [9, 11]. Difficulties with ejaculation were not correlated with the age of patients (p > 0.05). Problems with ejaculation were least frequent among patients prior to cancer treatment, while all the posttreatment patients reported having such difficulties. Patients who received surgical treatment, hormone therapy or both radiotherapy and hormone therapy had no problems with ejaculation. Sullivan et al. [37] determined that radiotherapy, especially if it is focused on the prostate gland, may be associated with anejaculation (inability to ejaculate). A study in 364 men diagnosed with prostate carcinoma and undergoing radiotherapy showed that as many as 72% of the patients experienced anejaculation. However, elderly men and patients receiving lower doses of radiation were less exposed to this side effect. This situation may lead to an intentional avoidance of orgasm by men suffering from prostate carcinoma. On the other hand, Wassersug et al. [12] noticed that the lack of ejaculation in men having homosexual relations caused particular discomfort. However, in our study, a feeling of embarrassment during intimate contact (in sexually active men) was not correlated with age but with the stage of cancer treatment and the type of therapy.
Embarrassment during sexual contact was not experienced by pretreatment patients, patients receiving surgical treatment, hormone therapy, or radiotherapy combined with hormone therapy. Additionally, none of the discussed aspects of sexual activity, in relation to all the patients or only those sexually active during the last 4 months, had no impact on the quality of life score (p > 0.05 for all cases). Harrington et al. [38] showed that men who underwent hormone therapy are exposed to verbal abuse due to changes in their appearance as a side effect of the therapy (weight gain, loss of muscle mass, reduced hair, gynecomastia). Reduced embarrassment and dissatisfaction with one’s own body was reported by men with the same diagnosis but undergoing treatment other than hormone therapy. A feeling of embarrassment is also caused by changes in body weight (weight gain or weight loss) which in turn affects the image of one’s own manhood [39, 40]. However, problems related to the body image are not necessarily focused only on the penis. In male patients treated for colorectal cancer, intestinal stoma was associated not only with erectile disorders but also with a feeling of shame before themselves and their partner.
Despite the existing psychoemotional disorders, no correlation was found between the age of patients and feeling tense, worried, irritable, or depressed. Additionally, complaints reported by sexually active patients showed no correlation between age and a sense of loss of manhood, erectile disorders, satisfaction with sexual life, or embarrassment during intimate contact.
The type and stage of cancer treatment (mostly prior to therapy) had a significant impact on feeling tense, worried, depressed, and irritable. It was also shown that feeling depressed affects the patient’s health status to a considerable extent. Our results show the urgent need to provide the patients with continuous psychological care, especially those waiting for treatment and those on treatment.
The method of treatment had no major impact on a sense of loss of manhood and the degree of sexual activity, while the stage of treatment (posttreatment patients and patients on treatment) had a negative effect on these parameters. Pretreatment patients declared high or very high satisfaction with their sexual life, while posttreatment patients and those on cancer treatment indicated low sexual satisfaction. However, feeling embarrassed during intimate contact as well as erectile disorders correlated both with the type and stage of cancer treatment. An analysis of the sexual functioning of prostate carcinoma men suggests that the patients should be under the care of a clinical sex therapist.
All authors declare no conflict of interests.
The study was financed from own funds.
This article does not contain any studies with animals performed by any of the authors.
The Ethical Committee consent for the presented research is not required. According to the statement of the Ethical Committee of the Medical University of Warsaw: “The Committee does not provide opinions on surveys, retrospective studies, or other non-invasive research” (Detailed information and templates of documents of Ethics Committee of Medical University of Warsaw (Accessed 2016-10-01):
Informed consent was obtained from all individual participants included in the study.
The company was founded in Vienna in 2004 by Alex Lazinica and Vedran Kordic, two PhD students researching robotics. While completing our PhDs, we found it difficult to access the research we needed. So, we decided to create a new Open Access publisher. A better one, where researchers like us could find the information they needed easily. The result is IntechOpen, an Open Access publisher that puts the academic needs of the researchers before the business interests of publishers.
",metaTitle:"Our story",metaDescription:"The company was founded in Vienna in 2004 by Alex Lazinica and Vedran Kordic, two PhD students researching robotics. While completing our PhDs, we found it difficult to access the research we needed. So, we decided to create a new Open Access publisher. A better one, where researchers like us could find the information they needed easily. The result is IntechOpen, an Open Access publisher that puts the academic needs of the researchers before the business interests of publishers.",metaKeywords:null,canonicalURL:"/page/our-story",contentRaw:'[{"type":"htmlEditorComponent","content":"We started by publishing journals and books from the fields of science we were most familiar with - AI, robotics, manufacturing and operations research. Through our growing network of institutions and authors, we soon expanded into related fields like environmental engineering, nanotechnology, computer science, renewable energy and electrical engineering, Today, we are the world’s largest Open Access publisher of scientific research, with over 4,200 books and 54,000 scientific works including peer-reviewed content from more than 116,000 scientists spanning 161 countries. Our authors range from globally-renowned Nobel Prize winners to up-and-coming researchers at the cutting edge of scientific discovery.
\\n\\nIn the same year that IntechOpen was founded, we launched what was at the time the first ever Open Access, peer-reviewed journal in its field: the International Journal of Advanced Robotic Systems (IJARS).
\\n\\n2004
\\n\\n2005
\\n\\n2006
\\n\\n2008
\\n\\n2009
\\n\\n2010
\\n\\n2011
\\n\\n2012
\\n\\n2013
\\n\\n2014
\\n\\n2015
\\n\\n2016
\\n\\n2017
\\n\\nWe started by publishing journals and books from the fields of science we were most familiar with - AI, robotics, manufacturing and operations research. Through our growing network of institutions and authors, we soon expanded into related fields like environmental engineering, nanotechnology, computer science, renewable energy and electrical engineering, Today, we are the world’s largest Open Access publisher of scientific research, with over 4,200 books and 54,000 scientific works including peer-reviewed content from more than 116,000 scientists spanning 161 countries. Our authors range from globally-renowned Nobel Prize winners to up-and-coming researchers at the cutting edge of scientific discovery.
\n\nIn the same year that IntechOpen was founded, we launched what was at the time the first ever Open Access, peer-reviewed journal in its field: the International Journal of Advanced Robotic Systems (IJARS).
\n\n2004
\n\n2005
\n\n2006
\n\n2008
\n\n2009
\n\n2010
\n\n2011
\n\n2012
\n\n2013
\n\n2014
\n\n2015
\n\n2016
\n\n2017
\n\n